Abbott Agrees to Settlement over Closure of Largest Baby Formula Plant in the US
The settlement resolves federal and state claims over contamination risks in powdered formula, with no finding of fault or liability.
- On Monday, Abbott Laboratories agreed to pay $385 million to resolve federal and state lawsuits regarding the safety of its powdered infant formulas, though the settlement includes no finding of fault or liability.
- Problems at the Sturgis, Michigan, facility prompted a 2022 recall and Justice Department lawsuit after the government alleged conditions included persistent roof leaks and cracks in spray dryers used for production.
- The Centers for Disease Control and Prevention did not identify a definitive link between Cronobacter cases and the plant, yet Abbott noted government tests of unopened products were negative for Cronobacter and Salmonella Newport.
- Acting Deputy Attorney General Trent McCotter called the agreement "a victory for American families", while Abbott stated it remains "deeply committed to earning and maintaining caregivers' trust".
- This agreement follows a separate $670 million settlement regarding Abbott's formula for premature infants, while the Justice Department under President Donald Trump closed its criminal investigation into the contamination matter.
98 Articles
98 Articles
Syracuse NY
Company behind 2022 formula shortage to pay $384M over tainted formula
Abbott Laboratories, the company behind the massive 2022 formula shortage that sparked widespread panic, has agreed to pay more than $384 million to settle allegations that it manufactured and sold potentially contaminated infant formula to government programs, according to the Department of Justice.
Abbott agrees to settle DOJ lawsuit over baby formula plant contamination
Abbott Laboratories will pay $385 million to settle allegation related to how it operated a manufacturing plant tied to contaminated powdered baby formula suspected of causing infant deaths. Contamination led to the nation's largest formula facility being shuttered temporarily in 2022, triggering a recall of several infant formula brands, including Similac, exacerbating existing supply chain...
DOJ announces $385 million settlement with Abbott over formula plant violations
WASHINGTON — Abbott Laboratories has agreed to pay nearly $385 million to settle allegations involving the safety and manufacturing of some of its powdered infant formula, the Justice Department announced Monday. The case involves formula made between 2018 and 2022 at Abbott plants in Sturgis, Michigan, and Casa Grande, Arizona. Federal officials alleged Abbott did… The post DOJ announces $385 million settlement with Abbott over formula plant vi…
Abbott agrees to settlement over closure of largest baby formula plant in the US - WSVN 7News | Miami News, Weather, Sports
(WSVN) — Abbott Laboratories will pay $385 million to resolve claims tied to an investigation of contamination at a baby formula factory in Sturgis, Michigan,...
The Dallas Express News
wbap.comAbbott Laboratories Agrees To Nearly $385 Million Settlement Over Infant Formula Allegations
Abbott Laboratories has agreed to pay nearly $385 million to settle allegations involving infant formula manufacturing and government-funded purchases, more than four years after a recall and factory shutdown worsened a nationwide formula shortage. The Justice Department announced the $384,999,040 civil settlement on Monday, September 14. The agreement resolves allegations that Abbott caused false claims […]
Coverage Details
Bias Distribution
- 61% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
